DIKER MANAGEMENT LLC

Position in LXRX — Lexicon Pharmaceuticals, Inc.

CIK 1276525 New York, NY

Position in LXRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$48,000

+$16,800 QoQ

Shares Held

20,000

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#95

of 149 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DIKER MANAGEMENT LLC holds $721,359 across 4 Biotechnology names. LXRX ranks #3 (6.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SPRY	ARS Pharmaceuticals, Inc.	65,508	$524,719
2	VNDA	Vanda Pharmaceuticals Inc.	21,880	$133,905
3	LXRX	Lexicon Pharmaceuticals, Inc. This page	20,000	$48,000
4	JSPR	Jasper Therapeutics, Inc.	35,000	$14,735

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,000	20,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$31,200	20,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.